Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cusack

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|April 26, 2013
CRM1 and BRAF inhibition synergize and induce tumor regression in BRAF-mutant melanomaRoberto A Salas Fragomeni, Hye Won Chung, Yosef Landesman, et al.
Molecular and Cellular Biology|June 1, 1995
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expressionL B Owen-Schaub, W Zhang, J C Cusack, et al.
Annals of Surgery|February 1, 1996
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study GroupG M Fuhrman, S D Leach, C A Staley, et al.
Annals of Surgical Oncology|October 26, 2020
Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon AdenocarcinomaYasmeen Z Qwaider, Naomi M Sell, Caitlin E Stafford, et al.
The British Journal of Radiology|June 15, 2017
Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant diseaseAmar U Kishan, Justin C Voog, Jonathan Wiseman, et al.
Cancer|November 1, 2006
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumorsDavid P Ryan, Bert H O'Neil, Jeffrey G Supko, et al.
American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.
Annals of Surgical Oncology|November 1, 2023
Trends and Determinants of Location of Death Due to Colorectal Cancer in the United States : A Nationwide StudySwati Sonal, Bhav Jain, Simar S Bajaj, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|April 26, 2013
CRM1 and BRAF inhibition synergize and induce tumor regression in BRAF-mutant melanomaRoberto A Salas Fragomeni, Hye Won Chung, Yosef Landesman, et al.
Molecular and Cellular Biology|June 1, 1995
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expressionL B Owen-Schaub, W Zhang, J C Cusack, et al.
Annals of Surgery|February 1, 1996
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study GroupG M Fuhrman, S D Leach, C A Staley, et al.
Annals of Surgical Oncology|October 26, 2020
Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon AdenocarcinomaYasmeen Z Qwaider, Naomi M Sell, Caitlin E Stafford, et al.
The British Journal of Radiology|June 15, 2017
Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant diseaseAmar U Kishan, Justin C Voog, Jonathan Wiseman, et al.
Cancer|November 1, 2006
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumorsDavid P Ryan, Bert H O'Neil, Jeffrey G Supko, et al.
American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.
Annals of Surgical Oncology|November 1, 2023
Trends and Determinants of Location of Death Due to Colorectal Cancer in the United States : A Nationwide StudySwati Sonal, Bhav Jain, Simar S Bajaj, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
Pageof 9